Sahin, S. Et Al. 2020. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-alpha. PAEDIATRICS AND INTERNATIONAL CHILD HEALTH , vol.40, no.1 , 65-68.

Sahin, S., Adrovic, A., Barut, K., Baran, S., Turanli, E., Canpolat, N., ... Kizilkilic, O.(2020). A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-alpha. PAEDIATRICS AND INTERNATIONAL CHILD HEALTH , vol.40, no.1, 65-68.

Sahin, Sezgin Et Al. "A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-alpha," PAEDIATRICS AND INTERNATIONAL CHILD HEALTH , vol.40, no.1, 65-68, 2020

Sahin, Sezgin Et Al. "A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-alpha." PAEDIATRICS AND INTERNATIONAL CHILD HEALTH , vol.40, no.1, pp.65-68, 2020

Sahin, S. Et Al. (2020) . "A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-alpha." PAEDIATRICS AND INTERNATIONAL CHILD HEALTH , vol.40, no.1, pp.65-68.

@article{article, author={Sezgin Sahin Et Al. }, title={A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-alpha}, journal={PAEDIATRICS AND INTERNATIONAL CHILD HEALTH}, year=2020, pages={65-68} }